The Wnt/β-catenin signaling and TGFβ signaling pathways play a key role in 
| INTRODUCTION
Osteoblast differentiation is controlled through a complex mechanism involving extracellular signaling molecules such as Wnt, transforming growth factor-beta (TGFβ), bone morphogenetic proteins (BMP), fibroblast growth factor, parathyroid hormone, Indian hedgehog, Sonic hedgehog, Notch, and insulin-like growth factors. Among them, Wnt and TGFβ play critical roles in multiple steps of osteoblast differentiation (Baron & Kneissel, 2013; Wu, Chen, & Li, 2016) . Expression of the signaling molecules has been shown to be regulated by multiple factors, including epigenetic factors and microRNAs (miRNAs). Although miRNAs are small, noncoding ribonucleic acids acting post-transcriptionally to repress gene expression and known to be involved in osteogenesis (Lian et al., 2012; Vimalraj & Selvamurugan, 2013) , miRNAs implicated in Wnt and TGFβ signaling networks during osteogenesis are still poorly understood.
Wnt3a, one of the canonical Wnt ligands, is known to play pleiotropic roles in regulating cell differentiation during mammalian osteogenesis. Wnt/β-catenin signaling promotes proliferation and differentiation in osteoblast precursor cells (Gaur et al., 2005; Rawadi, Vayssiere, Dunn, Baron, & Roman-Roman, 2003) . In contrast, canonical Wnt/β-catenin signaling has been shown to suppress osteoblast differentiation at late stages (de Boer, Wang, & van Blitterswijk, 2004; Boland, Perkins, Hall, & Tuan, 2004; Cho et al., 2006; van der Horst et al., 2005) . Mutations in Wnt/β-catenin signaling result in skeletal malformation in mouse and human (Baron & Kneissel, 2013) . Moreover, the Wnt pathway plays | Genes to Cells FUSHIMI et al. an important role for controlling self-renewal and differentiation states in stem cells (Ahmadzadeh, Norozi, Shahrabi, Shahjahani, & Saki, 2016; He et al., 2015; Luis, Ichii, Brugman, Kincade, & Staal, 2012; Naito et al., 2006) . Wnt signals promote cardiogenesis but inhibit hematopoiesis at early stages of development, whereas Wnt signals inhibit cardiomyocyte differentiation but promote blood cell differentiation at late stages of development (Naito et al., 2006) . Thus, Wnt3a is considered to perform stage-and cell type-specific functions during osteogenesis. However, little is known about the mechanisms underlying the physiological changes.
The TGFβ superfamily is a family of approximately 40 members, such as TGFβs, Activin, and BMPs (Chen, Deng, & Li, 2012; Feng & Derynck, 2005; Guo & Wang, 2009; Wu et al., 2016) . TGFβ signaling also plays pleiotropic roles in osteoblast differentiation (Tang & Alliston, 2013; Wu et al., 2016) . TGFβ/Smad signaling promotes proliferation, chemotaxis, and early differentiation of osteoprogenitor cells (Derynck, Piek, Schneider, Choy, & Alliston, 2008) . However, TGFβ later inhibits osteoblast maturation, mineralization, and transition into osteocytes (Alliston, Choy, Ducy, Karsenty, & Derynck, 2001; Kang, Alliston, Delston, & Derynck, 2005; Maeda, Hayashi, Komiya, Imamura, & Miyazono, 2004; Wu et al., 2016) . Thus, TGFβ also seems to play stage-specific roles during differentiation in osteogenesis. The three isoforms of TGFβs, that is, TGFβ1, TGFβ2, and TGFβ3, are known in mammals based on sequence homology (Feng & Derynck, 2005; Kingsley, 1994; Okamura et al., 2015) . However, the structure of TGFβ3 differs from that of TGFβ1 and TGFβ2 in its tertiary structure of the active domain (Laverty, Wakefield, Occleston, O'Kane, & Ferguson, 2009) .
We have previously shown that Wnt/β-catenin signaling acts as a molecular switch from proliferation to differentiation (Tanaka, Terada, & Nohno, 2011) and that BMP/Smad pathways are modified through Wnt signaling (Terada, Misao, Katase, Nishimatsu, & Nohno, 2013) . Furthermore, several miRNAs have been shown to have functional roles in skeletal muscle differentiation (Katase, Terada, Suzuki, Nishimatsu, & Nohno, 2015) . As it is currently unclear whether miRNAs are involved in Wnt3a and TGFβ signaling pathways during osteoblast differentiation, here, we investigated the role of miRNAs associated with TGFβ expression under control of Wnt3a.
| RESULTS

| Effect of Wnt3a over-expression on
MC3T3-E1 cells
First, we examined endogenous Wnt3a gene expression in MC3T3-E1 cells by real-time PCR, but Wnt3a mRNA was not detected during a 7-day culture (data not shown). In addition, we compared expression of the osteoblast-related genes in enhanced green fluorescent protein (eGFP)-overexpressing and uninfected MC3T3-E1 cells. There were no significant differences between them. Thus, we used enhanced green fluorescent protein eGFP-over-expressed cells as control in the following experiments.
Using Alkaline phosphatase (ALP) staining as an early osteoblast marker, we evaluated the characterization of Wnt3a-overexpressing cells and compared them with those of noncanonical Wnt4-and Wnt5a-over-expressing cells. The signal intensity in ALP staining was increased in Wnt3a-over-expressing cells compared with eGFP-over-expressing cells. In contrast, no significant changes in staining intensity were observed in the Wnt4-and Wnt5a-over-expressing cells (Figure 1a ). Large-size cells strongly expressing ALP were observed at day 3 after Wnt3a over-expression (Figure 1b) . Although Wnt3a over-expression did not affect cell proliferation (Figure 1c) , the ratio of ALPpositive cells was increased (Figure 1d ). β-catenin signaling activation was determined by Western blot analysis at day 1 after Wnt3a over-expression. Overexpression of Wnt3a resulted in approximately a twofold increase Genes to Cells in β-catenin signaling activity (phospho-β-catenin/β-actin ratio) ( Figure 2a ). To further evaluate osteoblast differentiation, realtime RT-PCR analyses of osteoblast-related genes were carried out. The ALP mRNA levels were increased at days 1 and 3 after Wnt3a over-expression ( Figure 2b ). In contrast, the expression levels of other osteoblast differentiation markers, type 1 collagen (Col1), runt-related transcription factor 2 (Runx2), and late-stage marker osteocalcin (OCN) (Aubin, 2001; Boskey, Wians, & Hauschka, 1985) , were significantly down-regulated in Wnt3a-over-expressing cells (Figure 2c -e). Furthermore, the protein level of the Runx2 transcription factor was decreased at day 3 after Wnt3a over-expression ( Figure 2f ). In contrast to the marked changes in Wnt3a over-expression, Wnt4 or Wnt5a overexpression did not affect osteoblast-related genes, except ALP at day 7 and Runx2 at day 3 in Wnt4 over-expression and OCN at day 3 in Wnt5a over-expression ( Figure S1 ); thus, we focused on Wnt3a over-expression afterward.
| miRNA microarray analysis
We compared the miRNA expression profiles of Wnt3a-over-expressing cells to those of eGFP-over-expressing cells at day 3 after Wnt3a over-expression ( Figure 3a) . Analysis of the miRNA expression profile showed that 14 miRNAs were up-regulated (>1 in log 2 ratio) and 21 miRNAs were downregulated (<−1 in log 2 ratio) in the Wnt3a-over-expressing cells. We then searched for miRNAs that satisfied the condition of global normalization values above 100. Furthermore, we determined the expression levels of miRNAs by realtime PCR analysis. We identified miR-140-3p, miR-140-5p, and miR-322-5p as significantly down-regulated miRNAs (Figure 3b ). We searched for miRNAs that targeted TGFβ ligand genes among significantly down-regulated miRNAs using microRNA.org (www.microrna.org/microrna/home.do), miRDB (mirdb.org/miRDB/), and DIANA-microT (diana. imis.athena-innovation.gr/DianaTools/) for the putative mRNA targets. TGFβ3 is considered to be a candidate gene for miR-140-3p. As the precursor miR-140 is encoded by an intronic region of the WWP2 gene (Nakamura et al., 2008; Yang et al., 2011) , the expression level of WWP2 at days 1, 3, and 7 after Wnt3a over-expression was determined by realtime PCR. WWP2 transcription was significantly decreased in Wnt3a-over-expressing cells (p < .001), suggesting that Wnt/β-catenin signaling is involved in miR-140-3p expression (Figure 3c ). There was no significant change in WWP2 expression levels during the 7-day culture in eGFP-overexpressing cells (Figure 3c ). Over-expression of Wnt4 and Wnt5a did not markedly change the miRNA expression profiles and WWP2 mRNA levels ( Figure S2a-d ).
| miR-140-3p directly targets TGFβ3
To evaluate the expression level of TGFβ3 after Wnt3a over-expression, real-time PCR and Western blot analysis were carried out. There was no significant change in TGFβ3 expression levels during the 7-day culture in eGFP-overexpressing cells (Figure 4a ). Wnt3a over-expression increased TGFβ3 expression at the mRNA and protein levels (Figure 4a,b) . Conversely, transfection of the miR-140-3p mimic led to inhibited TGFβ3 expression at both the mRNA and protein levels (Figure 4c,d ). To examine whether TGFβ3 3′UTR contains direct binding sites for miR-140-3p, we transiently cotransfected MC3T3-E1 cells with wild-type or mutant TGFβ3 3′UTR luciferase reporter plasmids (Figure 4e ) and the miR-140-3p mimic or negative control mimic (miR-NC). In these cells, miR-140-3p decreased luciferase activity of the wild-type TGFβ3 3′UTR by 35% compared with the negative control. Moreover, cotransfection with the mutant plasmids and miR-140-3p mimic or miR-NC had no significant effect on luciferase activity. These results suggest that the TGFβ3 3′UTR region in the reporter contains the target sequences for miR-140-3p (Figure 4f ).
| Effect of miR-140-3p transfection on
MC3T3-E1 cells
To investigate the function of miR-140-3p in osteoblast differentiation, we carried out gain-of-function experiments for miR-140-3p in MC3T3-E1 cells. The expressions of osteoblast-related genes were evaluated after miR-140-3p mimic transfection. Transfection of the miRNA mimic significantly increased OCN transcript levels, but did not affect the mRNA levels of ALP, Col1, and Runx2 (Figure 5a ). We further investigated whether or not rTGFβ3 treatment affected MC3T3-E1 cells and found that OCN mRNA expression was significantly inhibited (Figure 5b ).
| DISCUSSION
The overall results of this study suggest the existence of interaction between Wnt3a and TGFβ3 signaling pathways in osteoblastic MC3T3-E1 cells; miR-140-3p is mediated in these signaling pathways. Wnt/β-catenin signaling plays an important role in bone formation in human. Loss of function of low-density lipoprotein receptor-related protein 5 (LRP5) causes osteoporosispseudoglioma, whereas a gain of function in mutant LRP5 causes an autosomal dominant disorder (Boyden et al., 2002; Gong et al., 2001 ). LRP5 acts as a coreceptor for Wnt, as a target for the inhibitory effects of Dickkopf. Thus, the canonical Wnt/β-catenin signaling pathway regulates osteoblastogenesis and has an effect on bone density. Down-regulation of Wnt/β-catenin signaling is required for induction of terminal osteoblast differentiation and matrix mineralization (Boyden et al., 2002; van der Horst et al., 2005) . We showed that Wnt3a over-expression increased transcription of the ALP gene and decreased transcription of the Runx2, Col1, and OCN genes in MC3T3-E1 cells. Moreover, Wnt3a over-expression increased Wnt/β-catenin signaling activity, as well as expression of ALP. Activation of Wnt/β-catenin signaling has been shown to induce ALP expression in vitro (Bain, Müller, Wang, & Papkoff, 2003; Rawadi et al., 2003) . Such change in gene expression after Wnt3a over-expression seemed to be mediated through the Wnt/β-catenin signaling pathway. Taken together, these results indicated that activation of the Wnt/β-catenin pathway was essential for early differentiation, but an excess of activation suppressed osteoblast differentiation.
TGFβ enhances recruitment and proliferation of mesenchymal cells during osteogenesis, but TGFβ inhibits osteoblast differentiation (Tang & Alliston, 2013) . As TGFβ has
F I G U R E 5 Functions of miR-140-3p in MC3T3-E1 cells. (A) ALP, Col1, Runx2
, and OCN mRNAs at 48 hr after miR-140-3p mimic transfection. GAPDH was used as an internal control. Data are expressed as mean ± SD (n = 6-7). **p < .01. (b) Real-time PCR of OCN mRNA after 5 ng/ml rTGFβ3 treatment. β-actin was used as an internal control. Data are expressed as mean ± SD (n = 4-5). **p < .01 three isoforms and functions in a stage-specific manner, the role of TGFβ3 in osteoblast differentiation is not clearly understood. TGFβ3 mRNA and protein are observed in mouse bone during development (Pelton, Dickinson, Moses, & Hogan, 1990; Pelton, Saxena, Jones, Moses, & Gold, 1991) . TGFβ3-null mice have an almost normal skeleton with a cleft palate defect and delayed pulmonary development, suggesting that TGFβ3 is necessary for mesenchymal cell differentiation (Kaartinen et al., 1995; Proetzel et al., 1995) . The TGFβ3 gene polymorphisms are involved in cleft lip and palate (Saleem, Rajendran, Moinak, Anna, & Pramod, 2012) . TGFβ3 inhibits osteogenic differentiation in human mesenchymal stem cells (hMSCs) (Moioli, Hong, & Mao, 2007) . Using the organotypic culture system of embryonic chick femora, TGFβ3 has an inhibitory effect on bone volume in the developing bone (Smith, Rashidi, Kanczler, Shakesheff, & Oreffo, 2015) . Thus, TGFβ3 plays an essential role in osteoblast differentiation as observed for TGFβ1 and TGFβ2, and the bifunctional roles of TGFβ3 may be played through the interactions with signaling networks that are modulated by miRNAs. Recent studies have shown a relationship between Wnt/β-catenin and TGFβ signaling. Wnt/β-catenin signaling promotes TGF-β signaling in fibroblasts and osteoblast (Carthy, Garmaroudi, Luo, & McManus, 2011; Chen, McLean, Carter, & Leask, 2007; McCarthy & Centrella, 2010; Wei et al., 2012) . TGF-β cooperates with Wnt signaling and promotes osteoblast differentiation of human mesenchymal stem cells (hMSCs) (Chen et al., 2012) . Our results suggest that Wnt3a controls TGFβ3 functions through regulation of miR-140-3p expression ( Figure 6 ). That is, miR-140-3p regulates expression of TGFβ3. Moreover, TGFβ3 regulates osteoblast differentiation.
Little is known about the role of miR-140-3p in osteoblast differentiation. miR-140 −/− mice showed a mild skeletal phenotype with a short stature and age-related OA-like changes (Miyaki et al., 2010) . The expression of miR-140-3p is shown to be up-regulated in the animal bone healing process (Tu, Tang, He, Cheng, & Chen, 2017; Waki et al., 2016) . miR-140-5p and miR-140-3p are enriched in undifferentiated hMSCs; miR-140-5p decreases during the initial steps and increases during the later phase of osteogenic differentiation (Hwang et al., 2014) . Zhang et al. (2015) showed that miR-140-5p is down-regulated during osteoblast differentiation and is capable of controlling adipogenesis and osteogenesis via direct regulation of TGFβ receptor 1. Change in the miR-140 expression level seems to play an important role in osteoblast differentiation and bone disease. In addition, Wnt3a over-expression increased ALP activity, but transfection of the miR-140-3p mimic had no effect on ALP mRNA, suggesting that ALP expression was not regulated by miR-140-3p/TGFβ3 signaling. Although over-expression of Wnt3a decreased Col1 and Runx2 mRNA, transfection of the miR-140-3p mimic had no effect on Col1 and Runx2 mRNA. These findings indicate that expression of Col1 and Runx2 was also not regulated by miR-140-3p/TGFβ3 signaling. We also found that miR-140-5p and miR-322-5p were significantly downregulated miRNAs involved in the Wnt3a/β-catenin signaling pathway. Further studies on the relationship between the Wnt3a/β-catenin signaling pathway and the miRNAs using the primary culture are needed for a better understanding of the mechanism of osteoblast differentiation, as reported by Zhu et al. (2017) for WWP2 knockdown in the primary osteoblast.
| CONCLUSIONS
In conclusion, miR-140-3p plays a regulatory role in the interaction between the Wnt3a/β-catenin and TGFβ3 signaling pathways during osteoblast differentiation. Genes to Cells FUSHIMI et al.
| ACCESSION NUMBER
Information about a microarray experiment-(MIAME-) compliant array data including raw data is deposited in the Gene Expression Omnibus (GEO) at NCBI with accession number GSE96757.
| EXPERIMENTAL PROCEDURES
| Cell culture
Murine osteoblastic MC3T3-E1 cells were obtained from the RIKEN Bioresource Center (Tsukuba, Japan). The MC3T3-E1 cells were maintained in phenol red-free α-MEM (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (Nichirei Biosciences, Tokyo, Japan) and antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin) (Nacalai Tesque, Kyoto, Japan).
| Adenovirus amplification and infection
Adenoviruses carrying Wnt3a, Wnt4, Wnt5a, or eGFP cDNA were prepared using the ViraPower Adenoviral Expression System (Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA), as described previously (Tanaka et al., 2011) . For viral infection, MC3T3-E1 was plated at either 2.5 × 10 4 cells/ well in 4-well plates or 1 × 10 5 cells/well in 6-well plates. After 24 hr, the cells were infected with the recombinant adenovirus at a multiplicity of infection of 200 and maintained for 1-7 days. MC3T3-E1 cells were harvested at days 1, 3, and 7 after viral infection for mRNA and at day 1 or 3 after viral infection for protein analysis.
| Alkaline phosphatase staining
For histological detection of ALP activity, cells were fixed with acetone/methanol at day 3 after Wnt3a, Wnt4, Wnt5a, or eGFP over-expression and stained using SIGMAFAST BCIP ® / NBT (B5655) (Sigma-Aldrich, St. Louis, MO, USA). Cells were stained with 4,6-diamidino-2-phenylindole (Dojindo, Kumamoto, Japan) for nuclear counterstain. The stained cells were photographed at 20× magnification with an All-in-One Fluorescence Microscope (Keyence, Osaka, Japan) to determine the percentage of ALP-positive cells and rate of cell proliferation. ALP-positive cells and total cells per area were determined by counting cell numbers in four randomly selected areas of eight independent cultures using measurement module BZ-H3C (Hybrid Cell Count Vers. 1.1, Keyence).
| Reverse transcription quantitative polymerase chain reaction (RT-qPCR)
Total RNA from MC3T3-E1 cell cultures was extracted using TRIzol (Ambion, Thermo Fisher Scientific, Waltham, MA, USA). Total RNA was reverse transcribed into cDNA using PrimeScript RT Master Mix (Takara Bio, Shiga, Japan). Real-time PCR was carried out on the Stratagene Mx3000P Real-time QPCR System (Agilent Technologies, Santa Clara, CA, USA) using Brilliant III Ultra-Fast QPCR Master Mixes (Agilent Technologies). TaqMan probes are indicated in Table 1 . The mRNA levels were normalized by GAPDH or β-actin using the ΔΔ method.
| miRNA expression analysis and miRNA RT-qPCR
For analysis of miRNA expression, MC3T3-E1 cells were harvested at day 3 after Wnt3a, Wnt4, Wnt5a, or eGFP overexpression. The miRNAs were extracted using the miRNeasy Mini Kit (Qiagen, Valencia, CA, USA). Expression profiles were examined under the following conditions: eGFP-overexpressing MC3T3-E1 cells vs. Wnt3a-over-expressing MC3T3-E1 cells; eGFP-over-expressing MC3T3-E1 cells vs. Wnt4-over-expressing MC3T3-E1 cells; eGFP-overexpressing MC3T3-E1 cells vs. Wnt5a-over-expressing MC3T3-E1 cells. Microarray analyses were carried out using the 3D-Gene miRNA Microarray Platform (Toray Industries, Inc., Tokyo, Japan). A search for predicted target mRNAs was carried out using the miRDB (Betel, Wilson, Gabow, Marks, & Sander, 2008) , MicroRNA.org (Wong & Wang, 2015) , and DIANA-microT databases (Paraskevopoulou et al., 2013) . For miRNA RT-qPCR, we designed primers for miRNAs and carried out quantitative PCR, as reported previously (Katase et al., 2015) . The PCR primers and poly(T) adaptor are indicated in Table 2 . The RNA was polyadenylated using a poly(A) Tailing Kit (Ambion) and reverse transcribed into cDNA using a PrimeScript RT Master Mix (Perfect Real Time) (Takara Bio) and poly(T) adaptor. PCR was carried out using Brilliant III Ultra-Fast SYBR Green QPCR Master Mixes (Agilent Technologies). RPS29 was used as an internal control.
T A B L E 1 TaqMan probes used in this study
Gene
Assay ID
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| Western blot analysis
Whole cell lysates were extracted using an EzRIPA Lysis Kit (ATTO, Tokyo, Japan). Protein samples were resolved by electrophoresis in 5%-20% polyacrylamide-SDS gel, transferred onto a polyvinylidene difluoride membrane (Merck Millipore, Darmstadt, Germany), and further processed for immunostaining. The membrane was blocked with 5% nonfat milk or PVDF Blocking Reagent for Can Get Signal (TOYOBO, Osaka, Japan) and subsequently incubated with primary antibodies overnight at 4°C with a horseradish peroxidase-conjugated secondary antibody (Amersham, GE Healthcare, Little Chalfont, UK) and with ECL Prime Western Blotting Detection Reagent (GE Healthcare).
To identify promotion of the trans activity of β-catenin (Taurin, Sandbo, Qin, Browning, & Dulin, 2006) , we used the following primary antibodies: anti-phospho-β-catenin (Ser675) (1:1,000, Cell Signaling Technology, Danvers, MA, USA), anti-β-catenin (1:1,000, Cell Signaling Technology), anti-TGFβ3 (1:1,000, Abcam, Cambridge, UK), anti-Runx2 (1:1,000, Cell Signaling Technology), and anti-β-actin (1:5,000, Sigma-Aldrich).
| Transfections of miRNA
For functional analysis, MC3T3-E1 cells were plated at 3 × 10 4 cells/well in 24-well plates in an antibiotic-free growth medium. After 24 hr, 10 nM of has-miR-140-3p (MC12503) mimic (Ambion) or miR-NC (Ambion)
were transfected into the cells with the Lipofectamine RNAiMAX transfection reagent (Life Technologies) according to the manufacturer's instructions. After another 24 hr, the medium was changed to a normal medium and then harvested after 2 days for RNA and 3 days for protein analysis. Transfection efficacy was confirmed by real-time RT-PCR analysis for PTK9 expression after miR-1-positive control (Ambion) transfection. miR-1-positive control transfection significantly decreased PTK9 expression compared to negative control (data not shown).
| Luciferase assay
To construct a luciferase reporter for a wild-type TGFβ3 3′-untranslated region (3′UTR), FANTOM clone G370121J04 was purchased from DNAFORM. Approximately 1 kb of the 3′UTR region was subcloned in a cloning vector bearing the kan gene in place of the bla gene in pBluescript (Promega, Madison, USA). Subsequently, the target sequences were subcloned in a pmirGLO vector (Promega). Mutated forms of TGFβ3 3′UTRs containing the presumed binding region were custom-synthesized by GeneArt (Life Technologies) and subcloned into the pmir-GLO vector (Promega).
For transfection, MC3T3-E1 cells were plated at 4 × 10 4 cells/well in 24-well plates. After 24 hr, the cells were cotransfected with 10 nM miR-140-3p mimics or miR-NC and 200 ng of luciferase plasmid DNA using the Lipofectamine 2000 Reagent (Life Technologies). The medium was changed to the normal medium at 5 hr after transfection. Cells were harvested at 24 hr after transfection in a cell lysis buffer and then assayed for luciferase activity using the Dual-Luciferase Reporter Assay System (Promega) following the manufacturer's protocol. Luminescence intensity was measured with a Minilumat LB9506 Luminometer (Berthold, Bad Wildbad, Germany).
| rTGFβ3 treatment
To assess the effects of rTGFβ3 on OCN gene expression, MC3T3-E1 cells were plated at 4 × 10 4 cells/well in 4-well plates. After 24 hr, the cells were treated with 5 ng/ml rTGFβ3 (Cell Signaling Technology) or vehicle and harvested at 2, 5, 24, and 72 hr for real-time PCR analysis.
| Data analysis
All data were expressed as means ± standard deviation (SD). Statistical analyses were carried out by Student's t test using JMP 9 software (SAS Institute Inc., Cary, NC, USA). p values <.05 were considered to be statistically significant. Poly (T) Adaptor 5′-gcg agc aca gaa tta ata cga ctc act ata ggt ttt ttt ttt ttc g-3′
T A B L E 2 Primers used in this study
Primer name Sequence
